4596 Kubota Pharmaceutical Holdings Co., Ltd. - Financial Results

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

4596

TSE Growth

Kubota Pharmaceutical Holdings Co., Ltd.

JPY

(+2.22%)

Dec 12, 3:30 pm JST

0.29

USD

Dec 12, 1:30 am EST

Result

ー

PTS

outside of trading hours

45.8

Dec 12, 11:51 pm JST

Summary Chart Historical News Financial Result

Current Period Guidance

Annual

Result

Guidance History

Growth Rate

Profitability

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Dec, 2021	0	-2,585	-2,616	-2,616	-57.5	0	Feb 14, 2022	IFRS
Dec, 2022	8	-2,038	-2,016	-2,016	-40.9	0	Feb 14, 2023	IFRS
Dec, 2023	40	-1,504	-1,490	-1,490	-26.8	0	Feb 14, 2024	IFRS
Dec, 2024	27	-1,289	-1,333	-1,333	-23.7	0	Feb 14, 2025	IFRS
Dec, 2025 Guidance	ー	ー	ー	ー	－	0	Feb 14, 2025	IFRS
YoY	－	－	－	－	－

Revision Direction	Revision Date	Revenue	Operating Profit	Ordinary Profit	Net Profit	Revised Dividend	Accounting Standards
Dec, 2020	Feb 13, 2020	40	-2,500	-2,400	-2,400	0	IFRS
	May 14, 2020	40	-3,000	-2,900	-2,900	0	IFRS
	Nov 13, 2020	38	-3,000	-2,900	-2,900	0	IFRS
Results	Feb 12, 2021	38	-2,484	-2,437	-2,437	0	IFRS
Dec, 2021	Feb 12, 2021	Available in future release
	Dec 16, 2021
Results	Feb 14, 2022
Dec, 2022	Feb 14, 2022
	Nov 11, 2022
Results	Feb 14, 2023
Dec, 2023	Feb 14, 2023
	Jan 31, 2024
Results	Feb 14, 2024
Dec, 2024	Feb 14, 2024
	Feb 12, 2025
Results	Feb 14, 2025
Dec, 2025	Feb 14, 2025	ー	ー	ー	ー	0	IFRS

Fiscal Year	Revenue	YoY	Operating Profit	YoY	Ordinary Profit	YoY	Adj. EPS	YoY
Dec, 2015	0	－	Available in future release
Dec, 2016	846	－
Dec, 2017	0	-100.0
Dec, 2018	0	－
Dec, 2019	0	－
Dec, 2020	38	－
Dec, 2021	0	-100.0
Dec, 2022	8	－
Dec, 2023	40	+400.0
Dec, 2024	27	-32.5
Dec, 2025 Guidance	ー	-100.0	ー	+100.0	ー	+100.0	－	+100.0

Fiscal Year	Revenue	Operating Profit	Operating Profit Margin	ROE	ROA	Total Asset Turnover Ratio	Adj. EPS
Dec, 2023	40	-1,504	-3,760	-45.19	-40.08	0.01	-26.8
Dec, 2024	27	-1,289	-4,774	-66.07	-58.50	0.01	-23.7
Dec, 2025 Guidance	ー	ー	ー	ー	ー	ー	－

All-Time High

	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS
Record	846	0	-1	-1	0.0
Fiscal Year	Dec, 2016	Dec, 2015	Dec, 2015	Dec, 2015	Dec, 2015

Second Half

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Jul - Dec, 2022	8	-866	-819	-819	-16.6	0	Feb 14, 2023	IFRS
Jul - Dec, 2023	23	-757	-745	-745	-13.4	0	Feb 14, 2024	IFRS
Jul - Dec, 2024	17	-614	-664	-664	-11.8	0	Feb 14, 2025	IFRS
Jul - Dec, 2025 Guidance	ー	ー	ー	ー	－	0	Feb 14, 2025	IFRS
YoY	－	－	－	－	－

Cash Flow

Annual

Fiscal Year	Operating Profit	Fee Cash Flow	Operating Cash Flow	Investing Cash Flow	Financial Cash Flow	Cash & Equivalents	Cash Ratio	Accounting Standards
Dec, 2022	-2,038	-1,581	-2,086	505	1,446	4,048	91.60	IFRS
Dec, 2023	-1,504	-1,380	-1,335	-45	96	2,767	91.74	IFRS
Dec, 2024	-1,289	-1,242	-1,199	-43	-88	1,454	94.35	IFRS

Actual Performance and Financial Trends

Accumulated Results 3rd Quarter

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Progress Rate vs. First Half	Announce	Accounting Standards
Jan - Sep, 2023	31	-1,031	-1,027	-1,027	-18.5	ー	Nov 14, 2023	IFRS
Jan - Sep, 2024	17	-955	-1,000	-1,000	-17.8	ー	Nov 14, 2024	IFRS
Jan - Sep, 2025	18	-654	-435	-435	-7.1	ー	Nov 14, 2025	IFRS
YoY	+5.9%	+31.5%	+56.5%	+56.5%	+60.1%

Quarterly Results

Result

Growth Rate

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Oct - Dec, 2023	9	-473	-463	-463	-8.3	-5,255.6	Feb 14, 2024	IFRS
Jan - Mar, 2024	5	-337	-343	-343	-6.1	-6,740.0	May 14, 2024	IFRS
Apr - Jun, 2024	5	-338	-326	-326	-5.8	-6,760.0	Aug 14, 2024	IFRS
Jul - Sep, 2024	7	-280	-331	-331	-5.9	-4,000.0	Nov 14, 2024	IFRS
Oct - Dec, 2024	10	-334	-333	-333	-5.9	-3,340.0	Feb 14, 2025	IFRS
Jan - Mar, 2025	7	-259	-259	-259	-4.5	-3,700.0	May 14, 2025	IFRS
Apr - Jun, 2025	6	-191	-191	-191	-3.3	-3,183.3	Aug 14, 2025	IFRS
Jul - Sep, 2025	5	-204	15	15	0.2	-4,080.0	Nov 14, 2025	IFRS
YoY	-28.6%	+27.1%	－	－	－

Fiscal Year	Revenue	YoY	Operating Profit	YoY	Ordinary Profit	YoY	Adj. EPS	YoY
Oct - Dec, 2020	0	－	Available in future release
Jan - Mar, 2021	0	－
Apr - Jun, 2021	0	-100.0
Jul - Sep, 2021	0	－
Oct - Dec, 2021	0	－
Jan - Mar, 2022	0	－
Apr - Jun, 2022	0	－
Jul - Sep, 2022	3	－
Oct - Dec, 2022	5	－
Jan - Mar, 2023	5	－
Apr - Jun, 2023	12	－
Jul - Sep, 2023	14	+366.7
Oct - Dec, 2023	9	+80.0
Jan - Mar, 2024	5	0.0
Apr - Jun, 2024	5	-58.3
Jul - Sep, 2024	7	-50.0
Oct - Dec, 2024	10	+11.1
Jan - Mar, 2025	7	+40.0
Apr - Jun, 2025	6	+20.0
Jul - Sep, 2025	5	-28.6	-204	+27.1	15	－	0.2	－

All-Time High Quarterly Results

	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS
Record	73	-191	15	15	0.2
Fiscal Year	Sep, 2016	Jun, 2025	Sep, 2025	Sep, 2025	Sep, 2025

Key Balance Sheet Figures

Fiscal Year	BPS	Equity Ratio	Total Asset	Equity	Retained Earnings	Interest-Bearing Debt Ratio	Announce	Accounting Standards
Dec, 2022	72.31	89.4	4,419	3,949	-24,180	0.04	Feb 14, 2023	IFRS
Dec, 2023	47.21	87.7	3,016	2,646	-25,670	0.05	Feb 14, 2024	IFRS
Dec, 2024	24.48	90.1	1,541	1,389	-25,056	0.01	Feb 14, 2025	IFRS
Jan - Sep, 2025	ー	94.0	1,843	1,732	-25,491	0.01	Nov 14, 2025	IFRS

Kubota Pharmaceutical Holdings Co., Ltd.(4596) Financial Results